Abstract:Apoptotic cell death was found to play a critical role in the development of diabetic cardiomyopathy. As one of pathogenic components of diabetes angiotensin II (Ang II) induced cardiac cell death in vitro and in vivo through induction of reactive oxygen and nitrogen species. However, Ang II-induced cell death signaling in the heart remains unclear. The present study was to investigate whether Ang II induces p53 expression and activation and if so, whether Ang II-induced cardiac cell death is p53-dependent, and whether a potent antioxidant metallothionein (MT) prevents Ang II-induced p53 expression, and associate apoptotic cell death signaling. A cardiac cell line (H9c2) was exposed to Ang II. We found that exposure of H9c2 cells to Ang II at 10, 50 and 100nM for 24h induced a significant apoptotic effect, measured by DNA fragmentation and cleaved caspase-3. Induction of apoptotic cell death by Ang II can be completely blocked by p53 inhibitor Pitithrin-α. Exposure of H9c2 cells to Ang II also significantly increased p53 phosphorylation, DNA double strand breaks and Bax/Bcl-2 ratio. All these effects were not observed in H9c2MT7 cells that forcedly overexpresses human MT-IIA gene, suggesting the preventive effect of antioxidant MT against Ang II-induced p53 activation and its apoptotic death signaling. Furthermore, the in vitro finding was validated in animal models by supplying Ang II to wild-type mice (WT) and MT-TG mice that has cardiac-specifically overexpressed MT gene. Ang II-induced significant up-regulation of p53 expression along with an increase in Bax/Bcl-2 ratio in the hearts of WT mice, but not MT-TG mice. These results suggest that Ang II-induced cardiac apoptotic cell death is mediated by p53 apoptotic signaling pathway, which is related to oxidative stress. Antioxidant MT can completely prevent Ang II-induced p53 activation and associated apoptotic effect in the heart.

Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of mitogen-activated protein kinases activation in vitro and in vivo.

Metallothionein Protects Against Doxorubicin-Induced Cardiomyopathy Through Inhibition of Superoxide Generation and Related Nitrosative Impairment

Metallothionein Inhibited DOX-induced Cardiac Apoptosis in Mice

Antioxidant Defense Against Anthracycline Cardiotoxicity by Metallothionein

Antiapoptotic Effect and Inhibition of Ischemia/Reperfusion-Induced Myocardial Injury in Metallothionein-Overexpressing Transgenic Mice

Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.

Metallothionein Prevents Intermittent Hypoxia-Induced Cardiac Endoplasmic Reticulum Stress and Cell Death Likely Via Activation of Akt Signaling Pathway in Mice.

Metallothionein (I/II) Suppresses Genotoxicity Caused by Dimethylarsinic Acid.

Metallothionein blocks oxidative DNA damage induced by acute inorganic arsenic exposure.

Inhibition Of Superoxide Generation And Associated Nitrosative Damage Is Involved In Metallothionein Prevention Of Diabetic Cardiomyopathy

Protective effects of metallothionein on isoproterenol-induced myocardial injury in rats

Angiotensin II-induced P53-Dependent Cardiac Apoptotic Cell Death: Its Prevention by Metallothionein

Inhibition of Tumor Necrosis Factor-Α-dependent Cardiomyocyte Apoptosis by Metallothionein

Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.

Attenuation of AngII‐induced Early Cell Death by MT Results in a Prevention of the Late Development of Cardiomyopathy

Attenuation of Doxorubicin Chronic Toxicity in Metallothionein-Overexpressing Transgenic Mouse Heart.

Prior Increase in Metallothionein Levels is Required to Prevent Doxorubicin Cardiotoxicity1

Metallothionein and Cardiovascular Diseases

Cardiac-specific overexpression of metallothionein attenuates L-NAME-induced myocardial contractile anomalies and apoptosis

Metallothionein Alleviates Oxidative Stress-Induced Endoplasmic Reticulum Stress and Myocardial Dysfunction

Antioxidant Metallothionein Alleviates Endoplasmic Reticulum Stress-Induced Myocardial Apoptosis and Contractile Dysfunction